Skip to main content

Table 3 Relation between HOX C13 expression and metastases localization

From: Increased HOX C13 expression in metastatic melanoma progression

HOX C13 Score

0

1

2

3

Sample N°

Lymph node met.

0 (0%)

2 (13,3%)

2 (13,3%)

11(73,3%)

15

Skin met.

1 (8,3%)

0 (0%)

4 (33,3%)

7 (58,3%)

12

Visceral met.

1 (4,8%)

4 (19,0%)

5 (23,8%)

11(52,4%)

21

     

48